Stevanato Group SpA Total Liabilities

Latest as of June 2026: $1.07 Billion USD

Stevanato Group SpA total liabilities. Based on the latest financial reports, Stevanato Group SpA (STVN) has total liabilities worth $1.07 Billion USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Stevanato Group SpA to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Stevanato Group SpA (2018–2025)

Total liabilities of Stevanato Group SpA from 2018 to 2025. This chart illustrates how Stevanato Group SpA's total liabilities have evolved over time, based on quarterly financial data. Explore STVN long-term investments to assets to see how much of total assets are deployed in long-term investments.

Stevanato Group SpA Competitors by Total Liabilities

The table below lists competitors of Stevanato Group SpA ranked by their total liabilities.

Company Country Total Liabilities
Zhejiang Dehong Automotive
SHG:603701
China CN¥856.20 Million
Equitas Small Finance Bank Limited
NSE:EQUITASBNK
India Rs-61.25 Billion
Cromwell Property Group
AU:CMW
Australia AU$887.80 Million
Hypoport SE
XETRA:HYQ
Germany €308.32 Million
China Union Holdings Ltd
SHE:000036
China CN¥1.69 Billion
Silicon Integrated Systems Corp
TW:2363
Taiwan NT$2.07 Billion
Atlas Energy Solutions Inc.
NYSE:AESI
USA $1.13 Billion
Kunming Chuan Jin Nuo Chemical Co Ltd
SHE:300505
China CN¥1.73 Billion

Liability Composition Analysis (2018–2025)

This chart breaks down Stevanato Group SpA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see STVN asset base.

Liquidity & Leverage Metrics

Stevanato Group SpA Total Liabilities Ratios Explained

Stevanato Group SpA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.61 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.69 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.41 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Stevanato Group SpA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Stevanato Group SpA (2018–2025)

The table below shows the annual total liabilities of Stevanato Group SpA from 2018 to 2025.

Year Total Liabilities Change
2025-12-31 $1.06 Billion +14.33%
2024-12-31 $924.43 Million -1.54%
2023-12-31 $938.93 Million +41.45%
2022-12-31 $663.79 Million +15.00%
2021-12-31 $577.18 Million -12.26%
2020-12-31 $657.84 Million +6.66%
2019-12-31 $616.74 Million +12.10%
2018-12-31 $550.18 Million --

About Stevanato Group SpA

NYSE:STVN USA Medical Instruments & Supplies
Market Cap
$676.22 Million
Market Cap Rank
#10385 Global
#2782 in USA
Share Price
$13.57
Change (1 day)
+2.73%
52-Week Range
$13.21 - $24.25
All Time High
$35.39
About

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprisi… Read more